Innate immune responses induced by CpG oligodeoxyribonucleotide stimulation of ovine blood mononuclear cells

Immunology

Volumn 110, Issue 2, 2003, Pages 250-257

  Mena, Angelo ^a   Nichani, Anil K ^a   Popowych, Yurij ^a   Godson, Dale L ^b   Dent, Donna ^a   Townsend, Hugh G G ^a   Mutwiri, George K ^a   Hecker, Rolf ^c   Babiuk, Lorne A ^a   Griebel, Philip ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c QIAGEN GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2' A OLIGOADENYLATE SYNTHETASE; 5' A OLIGOADENYLATE SYNTHETASE; ALPHA INTERFERON; CYTOSINE PHOSPHATE GUANOSINE OLIGODEOXYRIBONUCLEOTIDE; GAMMA INTERFERON; ISOENZYME; RECOMBINANT DNA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVITY; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; ENZYME ACTIVITY; EXPERIMENTAL MODEL; FEMALE; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MONONUCLEAR CELL; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SHEEP;

2',5'-OLIGOADENYLATE SYNTHETASE; ANIMALS; CPG ISLANDS; CULTURE TECHNIQUES; FEMALE; INTERFERON TYPE II; INTERFERON-ALPHA; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MALE; OLIGODEOXYRIBONUCLEOTIDES; SHEEP, DOMESTIC; SPECIES SPECIFICITY;

EID: 0141922941     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2003.01722.x     Document Type: Article

References (63)

1. Coley WB. The treatment of malignant tumors by repeated inoculations of erysipelas with a report of ten original cases 1893. Clin Orthop 1991; 262:3-11.
2. Wiemann B, Starnes CO. Coley's toxins, tumor necrosis factor and cancer research: a historical perspective. Pharmacol Ther 1994; 64:529-64.
3. Tokunaga T, Yamamoto H, Shimada S et al. Antitumor activity of deoxyribonucleic acid fraction from Mycobacierium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J Natl Cancer Inst 1984; 72:955-62.
4. Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klinman DM. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995; 374:546-9.
5. Elkins KL, Rhinehart-Jones TR, Stibitz S, Conover JS, Klinman DM. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J Immunol 1999; 162:2291-8.
6. Gramzinski RA, Doolan DL, Sedegah M, Davis HL, Krieg AM, Hoffman SL. Interleukin-12- and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice. Infect Immun 2001; 69:1643-9.
7. Klinman DM, Conover J, Coban C. Repeated administration of synthetic oligodeoxynucleotides expressing CpG motifs provides long-term protection against bacterial infection. Infect Immun 1999; 67:5658-63.
8. Krieg AM, Love-Homan L, Yi AK, Harty JT. CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J Immunol 1998; 161:2428-34.
9. Walker PS, Scharton-Kersten T, Krieg AM, Love-Homan L, Rowton ED, Udey MC, Vogel JC. Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma- dependent mechanisms. Proc Natl Acad Sci USA 1999; 96:6970-5.
10. Weighardt H, Feterowski C, Veit M, Rump M, Wagner H. Holzmann B. Increased resistance against acute polymicrobial sepsis in mice challenged with immunostimulatory CpG oligodeoxynucleotides is related to an enhanced innate effector cell response. J Immunol 2000; 165:4537-43.
11. Zimmermann S, Egeter O, Hausmann S, Lipford GB, Rocken M, Wagner H, Heeg K. CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. J Immunol 1998; 160:3627-30.
12. Hemmi H, Takeuchi O, Kawai T et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408:740-5.
13. Kaisho T, Akira S. Dendritic-cell function in Toll-like receptor- and MyD88-knockout mice. Trends Immunol 2001; 22:78-83.
14. Bauer S, Kirschning CJ, Hacker H, Redecke V, Hausmann S, Akira S, Wagner H, Lipford GB. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci USA 2001; 98:9237-42.
15. Stacey KJ, Sweet MJ, Hume DA. Macrophages ingest and are activated by bacterial DNA. J Immunol 1996; 157:2116-22.
16. Sparwasser T, Miethke T, Lipford G, Erdmann A, Hacker H, Heeg K, Wagner H. Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock. Eur J Immunol 1997; 27:1671-9.
17. Sparwasser T, Miethke T, Lipford G, Borschert K, Hacker H, Heeg K, Wagner H. Bacterial DNA causes septic shock. Nature 1997; 386:336-7.
18. Jakob T, Walker PS, Krieg AM, Udey MC, Vogel JC. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides. A role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J Immunol 1998; 161:3042-9.
19. Hartmann G, Krieg AM. CpG DNA and LPS induce distinct patterns of activation in human monocytes. Gene Ther 1999; 6:893-903.
20. Krieg AM. Now I know my CpGs. Trends Microbiol 2001; 9: 249-52.
21. Krug A, Rothenfusser S, Hornung V et al. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur J Immunol 2001; 31:2154-63.
22. Ballas ZK, Rasmussen WL, Krieg AM. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J Immunol 1996; 157:1840-5.
23. Kawarada Y, Ganss R, Garbi N, Sacher T, Arnold B, Hammerling GJ. NK- and CD8(+) T cell-mediated eradication of established tumors by peritumoral injection of CpG-containing oligodeoxynucleotides. J Immunol 2001; 167:5247-53.
24. Yi AK, Klinman DM, Martin TL, Matson S, Krieg AM. Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway. J Immunol 1996; 157:5394-402.
25. Yi AK, Hornbeck P, Lafrenz DE, Krieg AM. CpG DNA rescue of murine B lymphoma cells from anti-IgM-induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-xL. J Immunol 1996; 157:4918-25.
26. Redford TW, Yi AK, Ward CT, Krieg AM. Cyclosporin A enhances IL-12 production by CpG motifs in bacterial DNA and synthetic oligodeoxynucleotides. J Immunol 1998; 161:3930-5.
27. Decker T, Schneller F, Sparwasser T, Tretter T, Lipford GB, Wagner H, Peschel C. Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells. Blood 2000; 95:999-1006.
28. Hartmann G, Krieg AM. Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J Immunol 2000; 164:944-53.
29. Jahrsdorfer B, Hartmann G, Racila E et al CpG DNA increases primary malignant B cell expression of costimulatory molecules and target antigens. J Leukoc Biol 2001; 69:81-8.
30. Verthelyi D, Ishii K, Gursel M, Takeshita F, Klinman D. Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs. J Immunol 2001; 166:2372-7.
31. Pestka S, Langer JA, Zoon KC, Samuel CE. Interferons and their actions. Annu Rev Biochem 1987; 56:727-77.
32. Staeheli P. Interferon-induced proteins and the antiviral state. Adv Virus Res 1990; 38:147-200.
33. Jacobs BL, Langland JO. When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology 1996; 219:339-49.
34. Kerr IM, Brown RE. pppA2′p5′A2′p5′A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interteron-treated cells. Proc Natl Acad Sci USA 1978; 75:256-60.
35. Silverman RH, Jung DD, Nolan-Sorden NL, Dieffenbach CW, Kedar VP, SenGupta DN. Purification and analysis of murine 2-5A-dependent RNase. J Biol Chem 1988; 263:7336-41.
36. Bisbal C, Salehzada T, Lebleu B, Bayard B. Characterization of two murine (2′-5′)(A)n-dependent endonucleases of different molecular mass. Eur J Biochem 1989; 179:595-602.
37. Baglioni C, Maroney PA, West DK. 2′5′Oligo(A)polymerase activity and inhibition of viral RNA synthesis in interferon-treated HeLa cells. Biochemistry 1979; 18:1765-70.
38. Nilsen TW, Maroney PA, Baglioni C. Synthesis of (2′-5′ )oligoadenylate and activation of an endoribonuclease in interferon-treated HeLa cells infected with reovirus. J Virol 1982; 42:1039-45.
39. Floyd-Smith G, Slattery E, Lengyel P. Interferon action. RNA cleavage pattern of a (2′-5′)oligoadenylate-dependent endonuclease. Science 1981; 212:1030-2.
40. Wreschner DH, McCauley JW, Skehel JJ, Kerr IM. Interferon action-sequence specificity of the ppp(A2′p)nA-dependent ribonuclease. Nature 1981; 289:414-7.
41. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 1999; 17:189-220.
42. Uthaisangsook S, Day NK, Bahna SL, Good RA. Haraguchi S. Innate immunity and its role against infections. Ann Allergy Asthma Immunol 2002; 88:253-64.
43. Lipford GB, Bendigs S, Heeg K, Wagner H. Poly-guanosine motifs costimulate antigen-reactive CD8 T cells while bacterial CpG-DNA affect T-cell activation via antigen-presenting cell- derived cytokines. Immunology 2000; 101:46-52.
44. Zhao Q, Temsamani J, Iadarola PL, Jiang Z, Agrawal S. Effect of different chemically modified oligodeoxynucleotides on immune stimulation. Biochem Pharmacol 1996; 51:173-82.
45. Gursel M, Verthelyi D, Gursel I, Ishii KJ, Klinman DM. Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotide. J Leukoc Biol 2002; 71:813-20.
46. Dudler L, Griebel PJ, Hein WR. Separation of mononuclear cells from blood. In: Lefkovits I, ed. Immunological Methods Manual: In Vitro Techniques in Experimental Immunology in Sheep, Vol. 4., London: Academic Press 1997:2075-78.
47. Mutwiri G, Bateman C, Baca-Estrada ME, Snider M, Griebel P. Induction of immune responses in newborn lambs following enteric immunization with a human adenovirus vaccine vector. Vaccine 2000; 19:1284-93.
48. Hughes HP, Rossow S, Campos M et al. A slow release formulation for recombinant bovine interferon alpha 1-1. Antiviral Res 1994; 23:33-44.
49. 3H]thymidine incorporation by 'control' oligonucleotides. Antisense Res Dev 1992; 2:325-30.
50. Tuo W, Ott TL, Bazer FW. Natural killer cell activity of lymphocytes exposed to ovine, type I, trophoblast interferon. Am J Reprod Immunol 1993; 29:26-34.
51. Segerson EC, Beetham PK. High-density ovine endometrial cells exhibit natural killer activity during early pregnancy. Theriogenology 2000; 54:1207-14.
52. Rankin R, Pontarollo R, Ioannou X, Krieg AM, Hecker R, Babiuk LA, van Drunen Littel-van den Hurk S. CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense Nucl Acid Drug Dev 2001; 11:333-40.
53. Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 2002; 20:709-60.
54. Yamamoto T, Yamamoto S, Kataoka T, Komuro K, Kohase M, Tokunaga T. Synthetic oligonucleotides with certain palindromes stimulate interferon production of human peripheral blood lymphocytes in vitro. Jpn J Cancer Res 1994; 85:775-9.
55. Yamamoto S, Yamamoto T, Shimada S, Kuramoto E, Yano O, Kataoka T, Tokunaga T. DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth. Microbiol Immunol 1992; 36:983-97.
56. Yamamoto S, Yamamoto T, Kataoka T. Kuramoto E, Yano O, Tokunaga T. Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN [correction of INF] and augment IFN-mediated [correction of INF] natural killer activity. J Immunol 1992; 148:4072-6.
57. Cowdery JS, Chace JH, Yi AK, Krieg AM. Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides. J Immunol 1996; 156:4570-5.
58. Krieg AM, Wagner H. Causing a commotion in the blood: immunotherapy progresses from bacteria to bacterial DNA. Immunol Today 2000; 21:521-6.
59. Pontarollo RA, Rankin R, Babiuk LA, Godson DL, Griebel PJ, Hecker R, Krieg AM, van Drunen Littel-van den Hurk S. Monocytes are required for optimum in vitro stimulation of bovine peripheral blood mononuclear cells by non-methylated CpG motifs. Vet Immunol Immunopathol 2002; 84:43-9.
60. Kadowaki N, Antonenko S, Liu YJ. Distinct CpG DNA and polyinosinic-polycytidylic acid double-stranded RNA, respectively, stimulate CD11c- type 2 dendritic cell precursors and CD11c+ dendritic cells to produce type I IFN. J Immunol 2001; 166: 2291-5.
61. Sun S, Zhang X, Tough D, Sprent J. Multiple effects of immunostimulatory DNA on T cells and the role of type I interferons. Springer Semin Immunopathol 2000; 22:77-84.
62. Iho S, Yamamoto T, Takahashi T, Yamamoto S. Oligodeoxynucleotides containing palindrome sequences with internal 5′-CpG-3′ act directly on human NK and activated T cells to induce IFN-gamma production in vitro. J Immunol 1999; 163: 3642-52.
63. Ballas ZK, Krieg AM, Warren T, Rasmussen W, Davis HL, Waldschmidt M, Weiner GJ. Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs. J Immunol 2001; 167:4878-86.